Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
M&A
Pharma
How Lundbeck’s CEO aims to keep firm ‘punching above its weight’
Lundbeck’s CEO, Charl van Zyl, told Fierce that he is confident the company can prove its mettle as a “neuroscience challenger.”
Fraiser Kansteiner
Aug 21, 2026 11:30am
Alfasigma gains drug, new territories with M&A play
Aug 12, 2026 11:23am
‘No discussions’ ongoing for AstraZeneca-BMS merger: Reuters
Aug 5, 2026 10:12am
Supernus-Indivior merger is about scale, business development
Aug 3, 2026 11:20am
Gerresheimer sheds pair of units in deal valued at €1.5B
Aug 3, 2026 9:40am
AZ leans on cancer, rare disease muscle in solid Q2
Jul 27, 2026 10:21am
